Stereotactic Biopsy vs Ultrasound Guided and MRI-Guided Biopsy

The core rule: guide by the modality that shows the lesion

Image-guided breast biopsy is generally performed under the modality on which the target is best and most reliably seen. Masses clearly visible on ultrasound are usually sampled under ultrasound; abnormalities seen only on mammography, such as microcalcifications, under stereotactic or tomosynthesis guidance; and findings seen only on MRI under MRI guidance.

Which method a particular patient receives is decided by the radiologist and the treating team, following local protocols. A centre planning services should therefore think in terms of lesion mix rather than preference.

Stereotactic biopsy vs ultrasound biopsy: strengths of each

Ultrasound guidance is real-time, involves no ionising radiation, is widely available and is generally more comfortable because the patient is supine and the needle can be seen as it moves. Equipment needs are a good ultrasound system with a high-frequency transducer, needles and a sterile set-up.

Stereotactic guidance is the established method for microcalcifications and for some architectural distortions, using two angled mammographic views to calculate the position. It requires a mammography unit with a stereotactic add-on, specimen radiography and a trained team. The Villa Melody IIID offers an optional stereotactic system with biopsy targeting accuracy of ±0.1 mm listed by the manufacturer; see stereotactic breast biopsy explained.

• Ultrasound: real time, no radiation, wide availability
• Stereotactic: suited to microcalcifications
• Stereotactic needs specimen radiography
• Both require a marker clip policy

Stereotactic biopsy vs MRI-guided biopsy

MRI-guided biopsy is used for lesions visible only on MRI. It requires MRI-compatible needles and a dedicated breast coil with biopsy capability, a longer room occupancy and contrast administration, which makes it more resource-intensive than the other two methods.

Many centres therefore refer MRI-only lesions to a centre with the capability and reserve their own capital for ultrasound and stereotactic or tomo-guided systems. Where tomosynthesis shows a finding better than 2D, tomo-guided biopsy may be relevant; see tomosynthesis-guided biopsy.

Equipment and cost drivers per procedure

Per-procedure cost depends on equipment depreciation, consumables (needles, markers), staff time, room occupancy and pathology. Ultrasound-guided procedures usually use equipment that is already in the department; stereotactic procedures need a biopsy-capable mammography unit and add-on; MRI procedures tie up scarce MRI time.

A mammography unit that can be upgraded, such as the Melody IIID, lets a centre add stereotactic and later tomo-guided capability when volumes justify it. The Melody IIID TS supports tomo-guided biopsy with the optional SBD DMD 3D device.

Radiology-pathology correlation and quality

Whatever the guidance method, the service is only as good as its feedback loop. Record the lesion, the device, the number of cores, whether calcifications were confirmed on the specimen radiograph and the pathology result, then review concordance regularly.

Discordant results should trigger a defined action, such as repeat sampling or surgical consultation, decided by the multidisciplinary team. Build this process into the service from the start and into the training of your staff.

Planning a breast biopsy service

Map your expected lesion mix, referral sources and pathology turnaround. Decide which methods you will offer in-house, train the team and create a quality programme that audits sampling adequacy and radiology-pathology concordance.

For equipment advice and quotations in the UAE, contact Beckfinity's specialists. Confirm current licensing for breast services with MOHAP, DHA or DOH.